ALFUZOSIN HCL EXTENDED RELEASE

The U.S. FDA approved Alfuzosin HCL Extended Release for benign prostatic hyperplasia on December 30, 2004. Alfuzosin HCL Extended Release is an alpha-adrenergic antagonist.

Alfuzosin HCL Extended Release is indicated for its use in treating Benign prostatic hyperplasia, a condition that causes enlargement of the prostate gland in men. The prostate gland is located under the urinary bladder; due to excess growth of the prostate gland, the urethra gets suppressed, leading to uncomfortable symptoms like difficulty in urination.

Take the tablets in the dose and duration prescribed by your physician. Alfuzosin HCL Extended release should preferably be taken after meals. Swallow the medication whole with a glass of water. Don't break, crush, or chew the tablet.

The most common side effects of Alfuzosin HCL Extended Release are sleepiness, trouble concentrating, dry mouth, dizziness, increase in appetite, drowsiness, and headache. While taking Alfuzosin HCL Extended Release, serious side effects are chest pain and allergic reactions- rashes, swelling, and trouble breathing.

Do not take this medicine if you are allergic to Alfuzosin HCL Extended Release or its ingredients. Do not take this medicine if you have liver problems. It is advised that you inform your doctor if you are already taking medicines of the same class, such as their alpha-blockers such as Doxazosin, Indoramin, Prazosin, Terazosin, Tamsulosin, or Phenoxybenzamine to avoid serious complications. Also, if you are taking medication to treat high blood pressure, heart disorders, or fungal infections, report it to your doctor immediately. If you have kidney impairment, birth defects of heartbeat or heart failure, and low blood pressure, talk to your doctor before starting your treatment with Alfuzosin HCL Extended release.

If you are above 65 years old and have been prescribed this tablet, be careful while performing your regular activities, as this tablet might make you more sensitive to developing low blood pressure. While using Alfuzosin HCL Extended release, you must notify your doctor about any planned surgical procedures to mitigate the risk of low blood pressure. This is a cancerous condition that commonly affects older men. While on your treatment with this tablet, it is highly unsafe to consume alcohol. Avoid handling machines or driving, as this tablet may cause dizziness and unusual tiredness.

Follow the dosage and administration instructions provided by your doctor. Inform your doctor of any known allergies or existing medical conditions prior to taking Alfuzosin HCL Extended Release. If you experience unexpected or severe side effects, such as difficulty breathing or signs of allergic reaction, seek immediate medical attention. Inform your healthcare professional of all other medications and supplements you are taking to prevent potential drug interactions. Address any concerns about your treatment with your doctor. Do not exceed the prescribed dose, as overdose may cause hypoglycaemia (low blood sugar).

Sanofi, Electronics Medicines Compendium (emc), [ Revised on September 2020] [Accessed on 30th August 2023], https://www.medicines.org.uk/emc/files/pil.1475.pdf Sanofi, U.S FDA, [ Revised on September 2013] [Accessed on August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021287s018lbl.pdf KD Tripathi, Essentials of Medical Pharmacology, Antiadrenergic drugs and drugs for glaucoma, 7th edition, 2013, 142.